Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James F Fries

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Rheumatology|October 6, 2005
Challenges and progress in adverse event ascertainment and reporting in clinical trialsMarissa N D Lassere, Kent R Johnson, Thasia G Woodworth, et al.
Expert Opinion on Drug Safety|October 21, 2011
Comparative risks of non-prescription analgesics: a structured topic review and research prioritiesEric J Lavonas, James F Fries, Daniel E Furst, et al.
Annals of the Rheumatic Diseases|August 12, 2006
Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokinesWolfgang Hueber, Beren H Tomooka, Xiaoyan Zhao, et al.
JAMA|January 13, 2006
Midlife body mass index and hospitalization and mortality in older ageLijing L Yan, Martha L Daviglus, Kiang Liu, et al.
Archives of Internal Medicine|May 11, 2005
Cardiovascular risk profile earlier in life and Medicare costs in the last year of lifeMartha L Daviglus, Kiang Liu, Amber Pirzada, et al.
Journal of the American Heart Association|December 29, 2018
Favorable Cardiovascular Health at Young and Middle Ages and Dementia in Older Age-The CHA StudyThanh-Huyen T Vu, Lihui Zhao, Lei Liu, et al.
Journal of Clinical Epidemiology|March 9, 2016
PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditionsKaron F Cook, Sally E Jensen, Benjamin D Schalet, et al.
Arthritis and Rheumatism|September 6, 2005
Antigen microarray profiling of autoantibodies in rheumatoid arthritisWolfgang Hueber, Brian A Kidd, Beren H Tomooka, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
The Journal of Rheumatology|August 3, 2011
Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomesJohn R Kirwan, James F Fries, Sarah E Hewlett, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Rheumatology|October 6, 2005
Challenges and progress in adverse event ascertainment and reporting in clinical trialsMarissa N D Lassere, Kent R Johnson, Thasia G Woodworth, et al.
Expert Opinion on Drug Safety|October 21, 2011
Comparative risks of non-prescription analgesics: a structured topic review and research prioritiesEric J Lavonas, James F Fries, Daniel E Furst, et al.
Annals of the Rheumatic Diseases|August 12, 2006
Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokinesWolfgang Hueber, Beren H Tomooka, Xiaoyan Zhao, et al.
JAMA|January 13, 2006
Midlife body mass index and hospitalization and mortality in older ageLijing L Yan, Martha L Daviglus, Kiang Liu, et al.
Archives of Internal Medicine|May 11, 2005
Cardiovascular risk profile earlier in life and Medicare costs in the last year of lifeMartha L Daviglus, Kiang Liu, Amber Pirzada, et al.
Journal of the American Heart Association|December 29, 2018
Favorable Cardiovascular Health at Young and Middle Ages and Dementia in Older Age-The CHA StudyThanh-Huyen T Vu, Lihui Zhao, Lei Liu, et al.
Journal of Clinical Epidemiology|March 9, 2016
PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditionsKaron F Cook, Sally E Jensen, Benjamin D Schalet, et al.
Arthritis and Rheumatism|September 6, 2005
Antigen microarray profiling of autoantibodies in rheumatoid arthritisWolfgang Hueber, Brian A Kidd, Beren H Tomooka, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
The Journal of Rheumatology|August 3, 2011
Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomesJohn R Kirwan, James F Fries, Sarah E Hewlett, et al.
Pageof 9